| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1101 | 2022 |
| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 889 | 2014 |
| Platelets mediate cytotoxic T lymphocyte–induced liver damage M Iannacone, G Sitia, M Isogawa, P Marchese, MG Castro, ... Nature medicine 11 (11), 1167-1169, 2005 | 446 | 2005 |
| Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression M Candolfi, JF Curtin, WS Nichols, AKMG Muhammad, GD King, ... Journal of neuro-oncology 85, 133-148, 2007 | 435 | 2007 |
| HMGB1 mediates endogenous TLR2 activation and brain tumor regression JF Curtin, N Liu, M Candolfi, W Xiong, H Assi, K Yagiz, MR Edwards, ... PLoS medicine 6 (1), e1000010, 2009 | 413 | 2009 |
| Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy … RA Dewey, G Morrissey, CM Cowsill, D Stone, F Bolognani, NJF Dodd, ... Nature medicine 5 (11), 1256-1263, 1999 | 388 | 1999 |
| Regulatable gene expression systems for gene therapy applications: progress and future challenges S Goverdhana, M Puntel, W Xiong, JM Zirger, C Barcia, JF Curtin, ... Molecular Therapy 12 (2), 189-211, 2005 | 374 | 2005 |
| ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma C Koschmann, AA Calinescu, FJ Nunez, A Mackay, J Fazal-Salom, ... Science translational medicine 8 (328), 328ra28-328ra28, 2016 | 297 | 2016 |
| Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity … CE Thomas, G Schiedner, S Kochanek, MG Castro, PR Löwenstein Proceedings of the National Academy of Sciences 97 (13), 7482-7487, 2000 | 295 | 2000 |
| Progress in gene therapy for neurological disorders M Simonato, J Bennett, NM Boulis, MG Castro, DJ Fink, WF Goins, ... Nature Reviews Neurology 9 (5), 277-291, 2013 | 280 | 2013 |
| Post-translational processing of proopiomelanocortin in the pituitary and in the brain MG Castro, E Morrison Critical Reviews™ in Neurobiology 11 (1), 1997 | 275 | 1997 |
| Current and future strategies for the treatment of malignant brain tumors MG Castro, R Cowen, IK Williamson, A David, MJ Jimenez-Dalmaroni, ... Pharmacology & therapeutics 98 (1), 71-108, 2003 | 272 | 2003 |
| IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response FJ Núñez, FM Mendez, P Kadiyala, MS Alghamri, MG Savelieff, ... Science translational medicine 11 (479), eaaq1427, 2019 | 255 | 2019 |
| Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy JV Gregory, P Kadiyala, R Doherty, M Cadena, S Habeel, E Ruoslahti, ... Nature communications 11 (1), 5687, 2020 | 230 | 2020 |
| High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiforme P Kadiyala, D Li, FM Nuñez, D Altshuler, R Doherty, R Kuai, M Yu, ... ACS nano 13 (2), 1365-1384, 2019 | 219 | 2019 |
| Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain CE Thomas, D Birkett, I Anozie, MG Castro, PR Lowenstein Molecular Therapy 3 (1), 36-46, 2001 | 211 | 2001 |
| Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses E Abordo-Adesida, A Follenzi, C Barcia, S Sciascia, MG Castro, L Naldini, ... Human gene therapy 16 (6), 741-751, 2005 | 200 | 2005 |
| Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination P Umana, CA Gerdes, D Stone, JRE Davis, D Ward, MG Castro, ... Nature biotechnology 19 (6), 582-585, 2001 | 191 | 2001 |
| Engineering patient-specific cancer immunotherapies L Scheetz, KS Park, Q Li, PR Lowenstein, MG Castro, A Schwendeman, ... Nature biomedical engineering 3 (10), 768-782, 2019 | 190 | 2019 |
| Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of … PR Lowenstein, RJ Mandel, W Xiong, K Kroeger, MG Castro Current gene therapy 7 (5), 347-360, 2007 | 190 | 2007 |
James F Curtin (ORCID: 0000-0002-9...Dean of Faculty of Engineering & Built EnvironmentVerified email at tudublin.ie
